Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06443762
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-05
First Post:
2024-05-29
Brief Title:
First Human Trial of Targeting MDM2MDMX PET Imaging
Sponsor:
Peking University Cancer Hospital Institute
Organization:
Peking University Cancer Hospital Institute
Study Overview
Official Title:
First in Human Study on PET Imaging of Solid Tumors Using an MDM2MDMX-Specific Probe
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Investigation of the Radiotracer Uptake of 68Ga MDM2MDMX Peptide at Lesion Sites in Patients with Malignant Tumors and Evaluation of the Capability of 68Ga MDM2MDMX Peptide to Detect Overexpression of MDM2MDMX in Tumor Patients Particularly Those with Recurrent or Advanced Disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None